Penumbra (PEN) Share-based Compensation (2014 - 2026)
Penumbra (PEN) posted quarterly Share-based Compensation of $13.7 million for Q2 2026, down 4.04% year-over-year from $14.2 million in Q2 2025, and down 6.73% quarter-over-quarter from $14.6 million in Q1 2026.
Penumbra (PEN) Share-based Compensation (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Share-based Compensation for 13 consecutive years, with $13.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Share-based Compensation fell 4.04% year-over-year to $13.7 million; the TTM figure through Jun 2026 stood at $59.5 million (up 16.54% YoY), while the FY2025 annual figure was $59.2 million, up 28.27% from the prior year.
- Share-based Compensation slipped to $13.7 million in Q2 2026 per PEN's latest filing, from $14.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $47.7 million in Q1 2022 and bottomed at $304000.0 in Q3 2022.
- Historically, Share-based Compensation has averaged $14.2 million across 5 years, with a median of $13.6 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 99.34% — and 2023, when it soared 4550.0%.
- Penumbra's Share-based Compensation stood at $20.8 million in 2022, then plunged by 48.08% to $10.8 million in 2023, then advanced by 12.08% to $12.1 million in 2024, then advanced by 26.18% to $15.3 million in 2025, then declined by 10.5% to $13.7 million in 2026.
- Business Quant data shows PEN's Share-based Compensation at $13.7 million in Q2 2026, $14.6 million in Q1 2026, and $15.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 13.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.66 Mn |
| Jun 30, 2026 | 13.66 Mn |
| Mar 31, 2026 | 14.65 Mn |
| Mar 31, 2026 | 14.65 Mn |
| Dec 31, 2025 | -41.41 Mn |
| Dec 31, 2025 | -41.41 Mn |
| Sep 30, 2025 | 41.14 Mn |
| Sep 30, 2025 | 41.14 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 838,000.00 |
| Mar 31, 2025 | 838,000.00 |
| Dec 31, 2024 | -31.68 Mn |
| Dec 31, 2024 | -31.68 Mn |
| Sep 30, 2024 | 33.56 Mn |
| Sep 30, 2024 | 33.56 Mn |
| Jun 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Mar 31, 2024 | 421,000.00 |
| Mar 31, 2024 | 421,000.00 |